A recent study on the contraceptive NuvaRing (manufactured by Merck & Co., Inc.) found that users of vaginal rings with ethinyl estradiol and etonogestrel (such as NuvaRing) have an increased risk of blood clots compared to non-users. As a result, lawsuits have been filed that allege the companies involved concealed the health risks associated with using the NuvaRing. … Read More